Heat Biologics Inc. (NASDAQ: HTBX) is 165.26% higher on its value in year-to-date trading and has touched a low of $0.19 and a high of $4.30 in the current 52-week trading range. The HTBX stock was last observed hovering at around $1.34 in the last trading session, with the day’s loss setting it -0.08% off its average median price target of $5.00 for the next 12 months. It is also 74.8% off the consensus price target high of $5.00 offered by 3 analysts, but current levels are 74.8% higher than the price target low of $5.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $1.26, the stock is -25.24% and -21.96% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.71 million and changing -5.97% at the moment leaves the stock 57.49% off its SMA200. HTBX registered 142.35% gain for a year compared to 6-month gain of 108.85%. The firm has a 50-day simple moving average (SMA 50) of $1.9440 and a 200-day simple moving average (SMA200) of $0.9784.
The stock witnessed a -41.94% loss in the last 1 month and extending the period to 3 months gives it a 57.99%, and is 5.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.50% over the week and 11.15% over the month.
Heat Biologics Inc. (HTBX) has around 36 employees, a market worth around $173.20M and $3.50M in sales. Distance from 52-week low is 546.15% and -70.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-151.80%).
Heat Biologics Inc. (HTBX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Heat Biologics Inc. (HTBX) is a “Buy”. 3 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Heat Biologics Inc. is expected to release its quarterly report on 11/12/2020 and quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $500k over the same period.The EPS is expected to grow by 33.20% this year, but quarterly earnings will post -34.70% year-over-year. Quarterly sales are estimated to grow 8,233.30% in year-over-year returns.
Heat Biologics Inc. (HTBX) Top Institutional Holders
19 institutions hold shares in Heat Biologics Inc. (HTBX), with 8.97M shares held by insiders accounting for 6.04% while institutional investors hold 14.43% of the company’s shares. The shares outstanding are 87.93M, and float is at 75.53M with Short Float at 6.78%. Institutions hold 13.56% of the Float.
Heat Biologics Inc. (HTBX) Insider Activity
A total of 2 insider transactions have happened at Heat Biologics Inc. (HTBX) in the last six months, with sales accounting for 1 and purchases happening 1 times.